基于ITS模型的带量采购政策对山东省药品使用影响研究

doi:10.3969/j.issn.1006-5253.2023.04.003

Abstract
Figure/Table
References (0)
Related Citation (2)

Download: PDF (3851 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Guide

Abstract Objective To evaluate the influence of centralized volume-based drug procurement policy on drug use in Shandong Province, and provide data support and decision-making reference for the subsequent promotion of drug procurement.Methods Based on the purchase data of 25 drugs in Shandong Province from January 2016 to April 2021, this paper analyzed the changes of drug purchase quantity, purchase amount, defined drug dose numbers (DDDs), defined daily dose cost (DDDc) and drug price index (DPI) before and after the implementation of the policy by using discontinuous time series method.Results After the policy implementation, drug purchase quantity and DDDs increased with obvious decrease of the purchase amount while DDDc and DPI dropped precipitously.Conclusion Centralized volume-based drug procurement policy is helpful to eliminate the phenomenon of "high drug price" and reduce the drug burden. It is suggested to increase the diversity of drugs and coordinate efforts with other mechanisms, so as to truly achieve the policy goal of benefiting people.

Key words： centralized volume-based drug procurement policy evaluation ITS analysis of the use

Received: 06 April 2023

PACS:

Fund:

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Chi Ying
	Wei Xinjiang
	Zhang Huifeng

Cite this article:

Chi Ying,Wei Xinjiang,Zhang Huifeng. Research on the influence of centralized volume-based drug procurement policy on drug use in Shandong Province based on ITS model[J]. journal1, 2023, 30(4): 253-257.

URL:

http://manu58.magtech.com.cn/Jwk_zgyytj/EN/10.3969/j.issn.1006-5253.2023.04.003 OR http://manu58.magtech.com.cn/Jwk_zgyytj/EN/Y2023/V30/I4/253

［1］国务院办公厅.国务院办公厅关于印发国家组织药品集中采购和使用试点方案的通知:国办发〔2019〕2号［A/OL］.(2019-01-17)［2023-02-02］.http://www.gov.cn/zhengce/content/2019-01/17/content_5358604.htm.

［2］国家医保局,工业和信息化部,财政部,等. 国家医疗保障局等九部门关于国家组织药品集中采购和使用试点扩大区域范围实施意见: 医保发〔2019〕56号［A/OL］.(2019-09-30)［2023-02-02］. http://www.nhsa.gov.cn/art/2019/9/30/art_37_1817.html.

［3］山东省人民政府办公厅关于印发山东省落实国家组织药品集中采购和使用试点扩围工作实施方案的通知: 鲁政办发〔2019〕26号［A/OL］.(2019-10-26)［2023-02-02］. http://www.shandong.gov.cn/art/2019/10/26/art_107851_78308.html.

［4］陈志洪，张洲驰．带量采购下中国药品市场变局：以降血脂药为例［J］．价格理论与实践，2019(12)：19-22．DOI: 10.19851/j.cnki.CN11-1010/F.2019.12.013.

［5］赵洁，李巍，王皋俊．价值医疗视角下国家药品集中带量采购在某公立医院的实施效果评价［J］．中国药房，2021，32(19)：2410-2414．DOI: 10.6039/j.issn.1001-0408.2021.19.18.

［6］陈丽萍，蒯丽萍，柳伟伟，等．医院心血管系统药物价格指数研究［J］．中国卫生经济，2021，40(3)：79-83．

［7］WAGNER A K, SOUMERAI S B, ZHANG F, et al. Segmented regression analysis of interrupted time series studies in medication use research［J］. J Clin Pharm Ther, 2002, 27(4):299-309. DOI: 10.1046/j.1365-2710.2002.00430.x.

［8］朱星月，林腾飞，米源，等．间断时间序列模型及其在卫生政策干预效果评价中的应用［J］．中国药事，2018，32(11)：1531-1540．DOI: 10.16153/j.1002-7777.2018.11.013.

［9］王雪梅，唐玉清，杜亚玲，等．基于间断时间序列模型的辅助用药监管政策干预效果研究［J］．中国卫生政策研究，2021，14(3)：57-63．DOI: 10.3969/j.issn.1674-2982.2021.03.009.［10］EMMERICK I C M, UY K, GUIAB K, et al. Impact of the National Lung Screening Trial (NLST) publication and Medicare Lung cancer screening payment on lung cancer incidence rates: An interrupted time series analysis［J］. J Cancer Policy, 2022, 31:100318. DOI: 10.1016/j.jcpo.2021.100318.

［11］徐阅，刘黎明，程薇．基于间断时间序列的北京市冠心病住院费用变化研究［J］．中国卫生经济，2021，40(9)：53-57．DOI: 10.3969/j.issn.1674-070X.2021.01.028.

［12］杨鹏，庞凡，赵清，等．基于间断时间序列模型的院前检查对平均住院日影响的研究［J］．中国医院统计，2021，28(1)：25-28．DOI: 10.3969/j.issn.1006-5253.2021.01.006.

［13］SHI T, MENG L, LI D, et al. Impact of the expanded program on immunization on the incidence of Japanese encephalitis in different regions of Mainland China: An interrupt time series analysis［J］. Acta Trop, 2022, 233:106575. DOI: 10.1016/j.actatropica.2022.106575.

［14］LINDEN A. Conducting interrupted time-series analysis for single- and multiple-group comparisons［J］. The Stata Journal, 2015, 15(2):480-500. DOI: 10.1177/1536867x1501500208.

［15］国家医疗保障局.国家医保局召开集采中选药品疗效和安全性真实世界研究成果发布会［A/OL］.(2021-06-11)［2023-04-01］.http://www.nhsa.gov.cn/art/2021/6/11/art_52_5263.html［16］岳小林，付娜，赵艳玲，等．国家集中带量采购中选药品疗效与安全性的真实世界研究［J］．临床药物治疗杂志，2022，20(6)：43-48．DOI: 10.3969/j.issn.1672-3384.2022.06.008.